Human Genome Sciences Initiates Phase 3 Clinical Trial Of … - Medical News Today (press release)
Human Genome Sciences Initiates Phase 3 Clinical Trial Of … - Medical News Today (press release)
Human Genome Sciences Initiates Phase 3 Clinical Trial Of …Medical News Today (press release), UK - 1 hour agoHuman Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has initiated dosing in ACHIEVE 2/3, a Phase 3 clinical trial of Albuferon(R) …Human Genome Sciences Initiates Phase 3 Clinical Trial of … PR Newswire (press release)Human Genome Sciences Announces Financial Results for 2006 and … PR Newswire (press release)Human Genome Sciences Announces Financial Results for 2006 and … Earthtimes.orgall 34 news articles